Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

Continuous subcutaneous insulin infusion (CSII) has become an indispensable modality in the management of type 1 diabetes. This therapy employs an insulin pump to deliver both basal and bolus doses, ...

There may be another leap toward an artificial pancreas thanks to new research released by Animas Corp. At the Advanced Technologies & Treatments for Diabetes Conference in February, the company, part ...

Please provide your email address to receive an email when new articles are posted on . Of 20 hospitals providing insulin algorithms, 60% stated which patients should initiate basal or nutritional ...

MILPITAS, Calif.--(BUSINESS WIRE)--Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced the acquisition of a reinforcement learning ...

The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...

The thin plastic tubing of infusion sets that connect insulin pumps to the body typically need to be changed every two or three days—but a new version in the U.S. more than doubles that timespan. The ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes achieve insulin independence within the year, a small phase I/II study ...

Findings of the review showed that continuous insulin infusion, coupled with standard oral lipid lowering therapies, successfully treated the hypertriglyceridemia. A case series published in the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A novel extended-wear insulin infusion set was usable ...